- Home
- MRK vs ABBV Comparison
MRK vs ABBV Comparison
Compare MRK & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- ABBV
- Stock Information
- Founded
- MRK 2000
- ABBV 2012
- Country
- MRK United States
- ABBV United States
- Employees
- MRK N/A
- ABBV N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- ABBV Biotechnology: Pharmaceutical Preparations
- Sector
- MRK Health Care
- ABBV Health Care
- Exchange
- MRK Nasdaq
- ABBV Nasdaq
- Market Cap
- MRK 260.8B
- ABBV 310.3B
- IPO Year
- MRK N/A
- ABBV N/A
- Fundamental
- Price
- MRK $96.23
- ABBV $172.58
- Analyst Decision
- MRK Buy
- ABBV Strong Buy
- Analyst Count
- MRK 15
- ABBV 22
- Target Price
- MRK $124.64
- ABBV $207.25
- AVG Volume (30 Days)
- MRK 9.7M
- ABBV 5.7M
- Earning Date
- MRK 02-04-2025
- ABBV 01-31-2025
- Dividend Yield
- MRK 3.38%
- ABBV 3.83%
- EPS Growth
- MRK 165.47
- ABBV N/A
- EPS
- MRK 4.78
- ABBV 2.87
- Revenue
- MRK $63,174,000,000.00
- ABBV $55,533,000,000.00
- Revenue This Year
- MRK $7.50
- ABBV $5.27
- Revenue Next Year
- MRK $5.14
- ABBV $5.63
- P/E Ratio
- MRK $20.14
- ABBV $60.14
- Revenue Growth
- MRK 6.51
- ABBV 0.72
- 52 Week Low
- MRK $94.48
- ABBV $153.58
- 52 Week High
- MRK $134.63
- ABBV $207.32
- Technical
- Relative Strength Index (RSI)
- MRK 37.73
- ABBV 42.35
- Support Level
- MRK $98.05
- ABBV $168.72
- Resistance Level
- MRK $100.90
- ABBV $177.98
- Average True Range (ATR)
- MRK 1.86
- ABBV 3.20
- MACD
- MRK -0.17
- ABBV -0.56
- Stochastic Oscillator
- MRK 6.52
- ABBV 28.70
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).